CD33-directed Immunoconjugate [EPC]

CD33-directed Immunoconjugate [EPC] was reported 3665 times

Drugs of the CD33-directed Immunoconjugate [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 GRANULICATELLA INFECTION 11 0.2619
1 CT HYPOTENSION COMPLEX 2 0.2000
2 DONOR LEUKOCYTE INFUSION 4 0.1538
3 GENOTOXICITY 5 0.1316
4 LI-FRAUMENI SYNDROME 2 0.1250
5 LEUKAEMIC INFILTRATION PULMONARY 4 0.0870
6 SUBDURAL ABSCESS 4 0.0870
7 ANORECTAL INFECTION BACTERIAL 1 0.0667
8 KETOSIS-PRONE DIABETES MELLITUS 3 0.0652
9 RETROGRADE PORTAL VEIN FLOW 2 0.0645
10 ANTI-HLA ANTIBODY TEST POSITIVE 1 0.0588
11 REFRACTORINESS TO PLATELET TRANSFUSION 6 0.0550
12 LEUKAEMIC INFILTRATION HEPATIC 2 0.0541
13 FIBRIN DEGRADATION PRODUCTS INCREASED 16 0.0541
14 VENOOCCLUSIVE LIVER DISEASE 260 0.0526
15 PERINEAL CELLULITIS 3 0.0508
16 HAEMORRHAGIC PNEUMONIA 3 0.0484
17 PNEUMONIA ASPERGILLUS 3 0.0462
18 BACTERIA BLOOD IDENTIFIED 6 0.0458
19 VENOOCCLUSIVE DISEASE 109 0.0435
20 COAGULATION FACTOR XIII LEVEL DECREASED 2 0.0385
21 LINEAGE SWITCH LEUKAEMIA 2 0.0377
22 ALLOGENIC BONE MARROW TRANSPLANTATION THERAPY 2 0.0370
23 CONGENITAL APLASIA 10 0.0322
24 LOWER RESPIRATORY TRACT INFECTION FUNGAL 12 0.0308
25 PERIANAL ABSCESS 3 0.0288
26 SERRATIA SEPSIS 3 0.0278
27 ACUTE MONOCYTIC LEUKAEMIA 5 0.0275
28 BLAST CELL COUNT DECREASED 2 0.0274
29 CRYPTOGENIC ORGANIZING PNEUMONIA 5 0.0260
30 LEUKAEMIA CUTIS 4 0.0260
31 CENTRAL LINE INFECTION 9 0.0243
32 ACUTE MYELOID LEUKAEMIA RECURRENT 51 0.0237
33 HAPTOGLOBIN ABNORMAL 2 0.0217
34 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 20 0.0216
35 BACTERIA STOOL IDENTIFIED 4 0.0211
36 HEPATIC VEIN OCCLUSION 3 0.0190
37 ALLOGENIC STEM CELL TRANSPLANTATION 3 0.0190
38 BLAST CELLS PRESENT 9 0.0187
39 BACILLUS BACTERAEMIA 2 0.0183
40 CAECITIS 8 0.0178
41 NEUTROPENIC INFECTION 17 0.0178
42 ACUTE MYELOID LEUKAEMIA REFRACTORY 3 0.0174
43 BLAST CELL COUNT INCREASED 18 0.0172
44 LEUKAEMIA RECURRENT 29 0.0171
45 INTESTINAL HAEMATOMA 3 0.0170
46 GALLOP RHYTHM PRESENT 2 0.0168
47 STENOTROPHOMONAS SEPSIS 2 0.0165
48 BLOOD BETA-D-GLUCAN INCREASED 5 0.0163
49 BILIARY NEOPLASM 2 0.0161
50 PULMONARY VENO-OCCLUSIVE DISEASE 11 0.0157
51 ACINETOBACTER SEPSIS 1 0.0156
52 ANAPLASTIC LYMPHOMA KINASE GENE MUTATION 1 0.0152
53 DIFFERENTIATION SYNDROME 11 0.0150
54 VENTRICULAR FLUTTER 2 0.0149
55 STREPTOCOCCAL BACTERAEMIA 16 0.0147
56 BLOOD BILIRUBIN DECREASED 9 0.0146
57 IIIRD NERVE DISORDER 2 0.0141
58 NEUTROPENIC COLITIS 29 0.0140
59 CLOSTRIDIUM DIFFICILE TOXIN TEST POSITIVE 2 0.0137
60 RESPIRATORY TRACT INFECTION FUNGAL 7 0.0133
61 NEUTROPHIL PERCENTAGE DECREASED 7 0.0131
62 ASPERGILLUS TEST POSITIVE 4 0.0130
63 CORONARY ARTERY DILATATION 2 0.0128
64 AMMONIA DECREASED 1 0.0128
65 SINUSITIS ASPERGILLUS 2 0.0127
66 STREPTOCOCCAL SEPSIS 15 0.0126
67 BLOOD CULTURE POSITIVE 36 0.0120
68 CHLOROMA 5 0.0118
69 ULTRASOUND DOPPLER ABNORMAL 2 0.0116
70 FUSARIUM INFECTION 8 0.0114
71 PERIORBITAL CELLULITIS 6 0.0112
72 ENTEROCOCCAL SEPSIS 9 0.0111
73 SPLENIC LESION 4 0.0108
74 INTRAVASCULAR HAEMOLYSIS 6 0.0107
75 LIVER TENDERNESS 3 0.0107
76 FEBRILE NEUTROPENIA 698 0.0105
77 AGONAL RHYTHM 1 0.0103
78 SKIN INFLAMMATION 2 0.0103
79 CENTRAL NERVOUS SYSTEM LEUKAEMIA 4 0.0102
80 MYELOID LEUKAEMIA 5 0.0100
81 UREAPLASMA INFECTION 4 0.0098
82 KLEBSIELLA SEPSIS 11 0.0098
83 ACUTE MYELOID LEUKAEMIA 151 0.0097
84 FUNGAL SEPSIS 8 0.0096
85 CATHETER SEPSIS 2 0.0096
86 BACTERIA URINE IDENTIFIED 2 0.0095
87 CATHETER RELATED INFECTION 9 0.0089
88 BIOPSY BONE MARROW ABNORMAL 4 0.0088
89 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 4 0.0086
90 ASPERGILLOSIS 11 0.0084
91 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 6 0.0083
92 APLASIA 16 0.0082
93 ENTEROBACTER SEPSIS 3 0.0081
94 PSEUDOMONAL SEPSIS 14 0.0080
95 ENTEROCOCCAL INFECTION 38 0.0079
96 BLOOD FIBRINOGEN INCREASED 6 0.0076
97 ENTEROCOCCAL BACTERAEMIA 8 0.0075
98 RESPIRATORY MONILIASIS 2 0.0075
99 ACUTE LYMPHOCYTIC LEUKAEMIA REFRACTORY 1 0.0074
100 ANTITHROMBIN III DECREASED 2 0.0073
101 CULTURE STOOL POSITIVE 2 0.0073
102 CULTURE POSITIVE 6 0.0072
103 HYPOCAPNIA 3 0.0072
104 URETERITIS 2 0.0071
105 BRONCHOPULMONARY ASPERGILLOSIS 55 0.0071
106 CEREBRAL FUNGAL INFECTION 2 0.0071
107 HAEMORRHAGIC OVARIAN CYST 4 0.0070
108 CATHETER SITE CELLULITIS 2 0.0068
109 ACUTE PROMYELOCYTIC LEUKAEMIA 7 0.0068
110 GRAFT VERSUS HOST DISEASE IN SKIN 15 0.0068
111 PNEUMATOSIS 3 0.0067
112 CANDIDA SEPSIS 6 0.0067
113 STAPHYLOCOCCAL SEPSIS 33 0.0067
114 BIOPSY LIVER ABNORMAL 2 0.0067
115 LUNG INJURY 2 0.0066
116 TRANSFUSION-RELATED ACUTE LUNG INJURY 2 0.0065
117 APOPTOSIS 2 0.0065
118 CULTURE URINE POSITIVE 9 0.0064
119 HEPATOBILIARY DISEASE 4 0.0064
120 HEPATIC CONGESTION 6 0.0063
121 BACILLUS INFECTION 4 0.0063
122 BOWEL SOUNDS ABNORMAL 2 0.0063
123 ASPERGILLOMA 2 0.0063
124 ACUTE GRAFT VERSUS HOST DISEASE 28 0.0061
125 PNEUMONIA FUNGAL 24 0.0061
126 NEUTROPENIC SEPSIS 43 0.0060
127 ACUTE RIGHT VENTRICULAR FAILURE 1 0.0059
128 PNEUMONIA ESCHERICHIA 2 0.0059
129 CLOSTRIDIUM COLITIS 7 0.0058
130 FUNGAEMIA 9 0.0057
131 ABSCESS FUNGAL 1 0.0057
132 BILIRUBIN CONJUGATED INCREASED 13 0.0056
133 ESCHERICHIA BACTERAEMIA 13 0.0055
134 PORTAL VENOUS GAS 2 0.0055
135 DISSEMINATED INTRAVASCULAR COAGULATION 77 0.0055
136 BONE MARROW FAILURE 109 0.0054
137 URINARY TRACT INFECTION FUNGAL 3 0.0052
138 ESCHERICHIA SEPSIS 15 0.0052
139 BLOOD BILIRUBIN INCREASED 138 0.0051
140 ALVEOLAR PROTEINOSIS 3 0.0051
141 EYE INFECTION TOXOPLASMAL 2 0.0050
142 GRUNTING 3 0.0050
143 LUNG CONSOLIDATION 14 0.0050
144 BRONCHITIS ACUTE 2 0.0050
145 MULTI-ORGAN FAILURE 84 0.0049
146 PULMONARY HAEMORRHAGE 37 0.0047
147 CLOSTRIDIAL INFECTION 16 0.0047
148 APPARENT LIFE THREATENING EVENT 2 0.0047
149 PSEUDOMONAL BACTERAEMIA 4 0.0047
150 BACTERIAL SEPSIS 15 0.0046
151 GRAFT VERSUS HOST DISEASE 33 0.0046
152 DEVICE RELATED SEPSIS 9 0.0045
153 REFUSAL OF TREATMENT BY RELATIVE 2 0.0044
154 MARROW HYPERPLASIA 3 0.0044
155 BACTERAEMIA 52 0.0044
156 PUPILS UNEQUAL 5 0.0044
157 CAPILLARY LEAK SYNDROME 9 0.0043
158 NEUROLOGICAL DECOMPENSATION 10 0.0043
159 ANGINA BULLOSA HAEMORRHAGICA 1 0.0043
160 CRANIAL NERVE DISORDER 3 0.0043
161 URINARY TRACT INFECTION ENTEROCOCCAL 4 0.0043
162 SYSTEMIC MYCOSIS 5 0.0043
163 ADENOVIRAL HEPATITIS 1 0.0043
164 ANAPLASTIC LARGE-CELL LYMPHOMA 1 0.0042
165 BLOOD ALKALINE PHOSPHATASE INCREASED 105 0.0042
166 HYPOPROTEINAEMIA 8 0.0042
167 CEREBELLAR HAEMORRHAGE 6 0.0042
168 GRAFT VERSUS HOST DISEASE IN LIVER 3 0.0042
169 CARDIAC ENZYMES INCREASED 3 0.0042
170 BLOOD LACTATE DEHYDROGENASE INCREASED 65 0.0041
171 CONTINUOUS HAEMODIAFILTRATION 4 0.0041
172 ACUTE RESPIRATORY DISTRESS SYNDROME 72 0.0041
173 BLOOD UREA DECREASED 5 0.0040
174 STEM CELL TRANSPLANT 10 0.0040
175 FEBRILE BONE MARROW APLASIA 17 0.0040
176 PHARYNGEAL ABSCESS 2 0.0040
177 ANORECTAL INFECTION 1 0.0040
178 ACUTE MYELOMONOCYTIC LEUKAEMIA 1 0.0040
179 HEPATOMEGALY 39 0.0040
180 GLUCOSE URINE PRESENT 5 0.0039
181 HEPATIC INFECTION 5 0.0039
182 ANAL INFECTION 1 0.0039
183 CEREBRAL ARTERY THROMBOSIS 2 0.0039
184 PULMONARY MYCOSIS 3 0.0039
185 LUNG INFILTRATION 34 0.0038
186 INFECTIOUS COLITIS 2 0.0038
187 STAPHYLOCOCCUS TEST POSITIVE 8 0.0038
188 PULMONARY MUCORMYCOSIS 2 0.0038
189 GASTRIC ANTRAL VASCULAR ECTASIA 2 0.0038
190 ELECTROMECHANICAL DISSOCIATION 3 0.0038
191 TUMOUR LYSIS SYNDROME 33 0.0037
192 ORAL INTAKE REDUCED 9 0.0037
193 STENOTROPHOMONAS INFECTION 5 0.0037
194 STAPHYLOCOCCAL BACTERAEMIA 16 0.0037
195 PERFORMANCE STATUS DECREASED 17 0.0036
196 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 10 0.0036
197 BLOOD PH INCREASED 2 0.0036
198 SEPTIC EMBOLUS 3 0.0036
199 COMPLEX PARTIAL SEIZURES 4 0.0036
200 ENTEROBACTER INFECTION 6 0.0036
201 AGONAL RESPIRATION 1 0.0035
202 ASPARTATE AMINOTRANSFERASE INCREASED 184 0.0035
203 MUCORMYCOSIS 9 0.0035
204 ENTEROCUTANEOUS FISTULA 3 0.0034
205 RESPIRATORY TRACT HAEMORRHAGE 2 0.0034
206 ENCEPHALITIS VIRAL 4 0.0033
207 HYPERBILIRUBINAEMIA 34 0.0033
208 OTITIS EXTERNA 4 0.0033
209 CEREBRAL ASPERGILLOSIS 2 0.0033
210 CALCULUS URINARY 5 0.0032
211 HYPOALBUMINAEMIA 25 0.0032
212 OVARIAN DISORDER 3 0.0032
213 PLEURAL DISORDER 2 0.0032
214 ABDOMINAL COMPARTMENT SYNDROME 2 0.0031
215 HYPERCHLORAEMIA 2 0.0031
216 PCO2 DECREASED 3 0.0031
217 PLATELET TRANSFUSION 4 0.0031
218 COMPUTERISED TOMOGRAM ABNORMAL 7 0.0031
219 ENTEROCOCCUS TEST POSITIVE 2 0.0031
220 PERITONEAL DISORDER 2 0.0031
221 ASPERGILLUS INFECTION 20 0.0030
222 CHRONIC GRAFT VERSUS HOST DISEASE 11 0.0030
223 LUNG NEOPLASM 13 0.0030
224 CHRONIC MYELOMONOCYTIC LEUKAEMIA 2 0.0030
225 NEOPLASM RECURRENCE 10 0.0029
226 SUBDURAL HAEMORRHAGE 8 0.0029
227 BLOOD CHLORIDE INCREASED 5 0.0029
228 ECHOCARDIOGRAM ABNORMAL 4 0.0029
229 SINUSITIS BACTERIAL 3 0.0028
230 PROTHROMBIN TIME PROLONGED 17 0.0028
231 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 4 0.0028
232 ASCITES 83 0.0028
233 ACQUIRED DIAPHRAGMATIC EVENTRATION 1 0.0028
234 SCROTAL OEDEMA 2 0.0028
235 INFECTION IN AN IMMUNOCOMPROMISED HOST 2 0.0028
236 PROTEUS INFECTION 2 0.0028
237 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 14 0.0028
238 ALANINE AMINOTRANSFERASE DECREASED 2 0.0028
239 PULMONARY SEPSIS 4 0.0027
240 SEPSIS 302 0.0027
241 PNEUMOCYSTIS JIROVECI PNEUMONIA 6 0.0027
242 CREATININE RENAL CLEARANCE INCREASED 2 0.0027
243 NEUTROPHIL COUNT DECREASED 109 0.0027
244 ALANINE AMINOTRANSFERASE INCREASED 163 0.0027
245 ANISOCORIA 1 0.0026
246 CEREBRAL VENTRICLE DILATATION 3 0.0026
247 HAEMATOCRIT DECREASED 51 0.0026
248 MEGACOLON 4 0.0025
249 LEFT VENTRICULAR DYSFUNCTION 17 0.0025
250 CELL DEATH 5 0.0025
251 SINUSITIS FUNGAL 2 0.0025
252 HEPATITIS VIRAL 2 0.0025
253 PLACENTAL INSUFFICIENCY 2 0.0025
254 SEPTIC SHOCK 108 0.0025
255 SPUTUM CULTURE POSITIVE 2 0.0025
256 CSF PROTEIN INCREASED 2 0.0024
257 CYTOLYTIC HEPATITIS 8 0.0024
258 SUBILEUS 5 0.0024
259 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 1 0.0024
260 HAEMODIALYSIS 20 0.0024
261 PANCYTOPENIA 133 0.0024
262 HEPATORENAL SYNDROME 4 0.0024
263 EROSIVE OESOPHAGITIS 4 0.0024
264 HEPATITIS FULMINANT 7 0.0024
265 BRONCHIAL SECRETION RETENTION 3 0.0024
266 HEPATOSPLENOMEGALY 6 0.0023
267 CATHETER SITE ERYTHEMA 5 0.0023
268 VENTRICULAR DYSFUNCTION 6 0.0023
269 HYPERAMMONAEMIC ENCEPHALOPATHY 4 0.0023
270 OBLITERATIVE BRONCHIOLITIS 3 0.0023
271 MUCOSAL INFLAMMATION 59 0.0023
272 CANDIDIASIS 9 0.0022
273 BLOOD MAGNESIUM INCREASED 2 0.0022
274 PLATELET COUNT DECREASED 236 0.0022
275 MUCOUS MEMBRANE DISORDER 3 0.0022
276 PNEUMONIA KLEBSIELLA 4 0.0022
277 KLEBSIELLA INFECTION 11 0.0022
278 LOBAR PNEUMONIA 4 0.0022
279 STREPTOCOCCAL INFECTION 12 0.0022
280 THROMBOCYTOPENIA 240 0.0021
281 CEREBRAL TOXOPLASMOSIS 2 0.0021
282 HUMAN HERPESVIRUS 6 INFECTION 4 0.0021
283 BONE MARROW TRANSPLANT 4 0.0021
284 KLEBSIELLA BACTERAEMIA 2 0.0021
285 HYPOXIA 74 0.0021
286 BLOOD UREA INCREASED 35 0.0021
287 ANAEMIA NEONATAL 1 0.0021
288 PNEUMONIA CYTOMEGALOVIRAL 4 0.0021
289 BONE MARROW DEPRESSION 2 0.0020
290 BRONCHOPNEUMONIA 7 0.0020
291 DACTYLITIS 2 0.0020
292 PNEUMONIA STAPHYLOCOCCAL 4 0.0020
293 HEMIANOPIA 2 0.0020
294 ABDOMINAL TENDERNESS 10 0.0020
295 ASPARTATE AMINOTRANSFERASE ABNORMAL 3 0.0020
296 ATELECTASIS 19 0.0020
297 HAEMORRHAGIC DIATHESIS 7 0.0020
298 INFUSION RELATED REACTION 130 0.0020
299 BLOOD CHLORIDE DECREASED 5 0.0019
300 HEPATIC FAILURE 58 0.0019
301 CEREBRAL HAEMORRHAGE 68 0.0019
302 BLOOD ALBUMIN DECREASED 15 0.0019
303 ASTERIXIS 2 0.0019
304 HYDROCELE 2 0.0019
305 PROTEIN TOTAL DECREASED 7 0.0019
306 GALLBLADDER ENLARGEMENT 2 0.0019
307 ACUTE LEUKAEMIA 3 0.0019
308 BLOOD SODIUM INCREASED 5 0.0019
309 HERPES SIMPLEX 12 0.0018
310 SHOCK HAEMORRHAGIC 15 0.0018
311 KIDNEY ENLARGEMENT 2 0.0018
312 BACTERIAL INFECTION 34 0.0018
313 PERIRECTAL ABSCESS 2 0.0018
314 CARDIOTOXICITY 16 0.0018
315 PSEUDOMEMBRANOUS COLITIS 4 0.0018
316 CATHETER RELATED COMPLICATION 2 0.0018
317 PLATELET COUNT INCREASED 23 0.0018
318 PULMONARY GRANULOMA 2 0.0018
319 CYSTITIS HAEMORRHAGIC 7 0.0017
320 ACUTE PRERENAL FAILURE 2 0.0017
321 HAEMOTHORAX 5 0.0017
322 APLASTIC ANAEMIA 9 0.0017
323 SPLENIC INFARCTION 3 0.0017
324 EPIDIDYMITIS 2 0.0017
325 FLUID OVERLOAD 25 0.0017
326 DILATATION ATRIAL 2 0.0017
327 GASTROINTESTINAL NECROSIS 5 0.0017
328 WHITE BLOOD CELL COUNT DECREASED 185 0.0017
329 PROCALCITONIN INCREASED 2 0.0017
330 ACIDOSIS 13 0.0017
331 NEOPLASM PROGRESSION 59 0.0017
332 TACHYPNOEA 23 0.0017
333 CYTOMEGALOVIRUS TEST POSITIVE 3 0.0017
334 INTRA-ABDOMINAL HAEMORRHAGE 4 0.0017
335 DIABETES INSIPIDUS 4 0.0017
336 MULTIPLE ORGAN DYSFUNCTION SYNDROME 47 0.0017
337 BONE MARROW DISORDER 5 0.0017
338 FEBRILE CONVULSION 2 0.0016
339 SOFT TISSUE INFECTION 3 0.0016
340 CHEST X-RAY ABNORMAL 5 0.0016
341 OPPORTUNISTIC INFECTION 3 0.0016
342 COAGULOPATHY 27 0.0016
343 HYPERVOLAEMIA 8 0.0016
344 RECTAL TENESMUS 2 0.0016
345 PULMONARY ALVEOLAR HAEMORRHAGE 9 0.0016
346 SYSTEMIC CANDIDA 4 0.0016
347 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0016
348 PLATELET DISORDER 4 0.0016
349 BLOOD BICARBONATE DECREASED 3 0.0016
350 BRAIN ABSCESS 4 0.0016
351 NECROTISING COLITIS 2 0.0016
352 BLOOD BILIRUBIN ABNORMAL 2 0.0016
353 PROCTALGIA 10 0.0016
354 PORTAL VEIN THROMBOSIS 5 0.0015
355 LIVER ABSCESS 5 0.0015
356 SPLENOMEGALY 18 0.0015
357 GAMMA-GLUTAMYLTRANSFERASE INCREASED 34 0.0015
358 PLEURAL EFFUSION 92 0.0015
359 INTESTINAL DILATATION 2 0.0015
360 APPENDICITIS 14 0.0015
361 HYPOPHYSITIS 3 0.0015
362 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
363 RESPIRATORY DISTRESS 41 0.0015
364 LEUKAEMIA 14 0.0015
365 HEPATOTOXICITY 33 0.0015
366 ANOREXIA 19 0.0015
367 ISCHAEMIC HEPATITIS 2 0.0015
368 HYPERURICAEMIA 6 0.0015
369 HYPOKALAEMIA 67 0.0015
370 BILIARY TRACT DISORDER 2 0.0014
371 PETECHIAE 15 0.0014
372 NEUTROPENIA 194 0.0014
373 THROMBOPHLEBITIS 5 0.0014
374 ALANINE AMINOTRANSFERASE ABNORMAL 3 0.0014
375 ALVEOLITIS 2 0.0014
376 IMMUNE THROMBOCYTOPENIC PURPURA 4 0.0014
377 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 3 0.0014
378 INTENSIVE CARE 2 0.0014
379 RETINAL HAEMORRHAGE 10 0.0014
380 DRUG RESISTANCE 36 0.0014
381 PSEUDOMONAS INFECTION 12 0.0014
382 ABSCESS INTESTINAL 3 0.0014
383 FUNGAL INFECTION 46 0.0014
384 APALLIC SYNDROME 1 0.0014
385 ENTEROCOLITIS HAEMORRHAGIC 2 0.0014
386 PNEUMONIA PNEUMOCOCCAL 2 0.0013
387 CHILLS 158 0.0013
388 BRAIN OEDEMA 17 0.0013
389 LIVER FUNCTION TEST ABNORMAL 39 0.0013
390 HAEMORRHAGE INTRACRANIAL 20 0.0013
391 THROMBOTIC MICROANGIOPATHY 13 0.0013
392 SUBDURAL HAEMATOMA 19 0.0013
393 BODY TEMPERATURE INCREASED 27 0.0013
394 CYTOMEGALOVIRUS COLITIS 3 0.0013
395 COLITIS 49 0.0013
396 ELECTROCARDIOGRAM T WAVE ABNORMAL 2 0.0013
397 RENAL FAILURE ACUTE 54 0.0013
398 HEPATIC FUNCTION ABNORMAL 47 0.0013
399 HAEMATOLOGICAL INFECTION 3 0.0012
400 LYMPHOCYTE COUNT INCREASED 4 0.0012
401 ENTEROCOLITIS 7 0.0012
402 DISEASE PROGRESSION 143 0.0012
403 HYPERNATRAEMIA 6 0.0012
404 TROPONIN I INCREASED 2 0.0012
405 HYPERAMMONAEMIA 6 0.0012
406 MENINGITIS 8 0.0012
407 VENTRICULAR HYPERTROPHY 3 0.0012
408 BILIARY DYSKINESIA 2 0.0012
409 HYPERTHERMIA 9 0.0012
410 DEVICE RELATED INFECTION 18 0.0012
411 PERICARDIAL EFFUSION 27 0.0012
412 HEPATIC FIBROSIS 4 0.0012
413 HAEMOLYSIS 9 0.0012
414 ADENOMA BENIGN 1 0.0012
415 TREATMENT DELAYED 2 0.0012
416 HEPATIC LESION 5 0.0012
417 PUPIL FIXED 2 0.0012
418 RESPIRATORY FAILURE 84 0.0012
419 HEPATITIS TOXIC 3 0.0012
420 ABDOMINAL SEPSIS 1 0.0011
421 THROMBOTIC THROMBOCYTOPENIC PURPURA 4 0.0011
422 CLOSTRIDIUM DIFFICILE COLITIS 12 0.0011
423 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
424 FIBRIN D DIMER INCREASED 4 0.0011
425 JUGULAR VEIN THROMBOSIS 2 0.0011
426 WHITE BLOOD CELL DISORDER 3 0.0011
427 ILEUS PARALYTIC 5 0.0011
428 HAEMATEMESIS 28 0.0011
429 BLOOD PHOSPHORUS INCREASED 3 0.0011
430 BLOOD PHOSPHORUS DECREASED 4 0.0011
431 ESCHERICHIA INFECTION 9 0.0011
432 EJECTION FRACTION DECREASED 17 0.0011
433 CONDUCTION DISORDER 2 0.0011
434 STAPHYLOCOCCAL INFECTION 36 0.0011
435 CHOLECYSTITIS 13 0.0011
436 MOUTH HAEMORRHAGE 8 0.0011
437 TENOSYNOVITIS 3 0.0011
438 SECOND PRIMARY MALIGNANCY 9 0.0011
439 HAEMOGLOBIN DECREASED 111 0.0011
440 SUBARACHNOID HAEMORRHAGE 11 0.0011
441 PULMONARY OEDEMA 48 0.0011
442 ACUTE PULMONARY OEDEMA 6 0.0011
443 HEPATIC NECROSIS 4 0.0011
444 CYTOPENIA 13 0.0011
445 CARDIAC TAMPONADE 5 0.0011
446 CARDIAC FAILURE ACUTE 7 0.0010
447 HAEMODYNAMIC INSTABILITY 8 0.0010
448 HYPOVOLAEMIC SHOCK 5 0.0010
449 SUDDEN DEATH 11 0.0010
450 BLOOD URIC ACID INCREASED 6 0.0010
451 MYELODYSPLASTIC SYNDROME 15 0.0010
452 GUILLAIN-BARRE SYNDROME 5 0.0010
453 PERIPHERAL SENSORY NEUROPATHY 6 0.0010
454 GASTROINTESTINAL INFLAMMATION 8 0.0010
455 RESPIRATORY RATE INCREASED 9 0.0010
456 BRAIN HERNIATION 3 0.0010
457 URINE ANALYSIS ABNORMAL 3 0.0010
458 PROTEIN URINE PRESENT 5 0.0010
459 HYPERCAPNIA 3 0.0010
460 MYELOFIBROSIS 3 0.0010
461 ACUTE RESPIRATORY FAILURE 19 0.0010
462 DIALYSIS 14 0.0010
463 RED BLOOD CELL COUNT DECREASED 28 0.0010
464 DIASTOLIC DYSFUNCTION 3 0.0010
465 OLIGURIA 6 0.0010
466 BLOOD BLISTER 3 0.0010
467 LIVEDO RETICULARIS 2 0.0010
468 LUNG ABSCESS 2 0.0010
469 DILATATION VENTRICULAR 2 0.0010
470 ELECTROENCEPHALOGRAM ABNORMAL 3 0.0009
471 CARDIOMYOPATHY 14 0.0009
472 LIVER DISORDER 42 0.0009
473 CENTRAL NERVOUS SYSTEM LESION 13 0.0009
474 OPTIC NEUROPATHY 2 0.0009
475 HYPERPYREXIA 4 0.0009
476 TRANSAMINASES INCREASED 21 0.0009
477 PYREXIA 326 0.0009
478 PHARYNGOLARYNGEAL PAIN 5 0.0009
479 SUPRAVENTRICULAR TACHYCARDIA 9 0.0009
480 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 7 0.0009
481 HYPERPHOSPHATAEMIA 2 0.0009
482 FACIAL PALSY 2 0.0009
483 OCULAR ICTERUS 4 0.0009
484 HYDROCEPHALUS 5 0.0009
485 ACINETOBACTER INFECTION 1 0.0009
486 INTESTINAL ISCHAEMIA 5 0.0009
487 CLOSTRIDIUM TEST POSITIVE 2 0.0009
488 PURPURA 8 0.0009
489 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 7 0.0009
490 MENTAL STATUS CHANGES 25 0.0009
491 ANGIOPATHY 5 0.0009
492 MENINGITIS ASEPTIC 4 0.0009
493 BLOOD CALCIUM DECREASED 10 0.0009
494 SUSPECTED OFF LABEL USE 4 0.0009
495 ILEUS 11 0.0009
496 CHOLECYSTITIS ACUTE 5 0.0009
497 HAEMOLYTIC URAEMIC SYNDROME 2 0.0009
498 DERMATITIS EXFOLIATIVE GENERALISED 3 0.0009
499 ERYTHEMA NODOSUM 3 0.0009
500 HYPOVOLAEMIA 5 0.0009
501 RASH MACULO-PAPULAR 19 0.0009
502 C-REACTIVE PROTEIN INCREASED 31 0.0009
503 HAEMATURIA 29 0.0008
504 BLOOD CREATININE INCREASED 55 0.0008
505 TRANSPLANT 2 0.0008
506 LONG QT SYNDROME 2 0.0008
507 GASTROINTESTINAL TOXICITY 4 0.0008
508 MONOCYTE COUNT INCREASED 3 0.0008
509 LYMPHADENITIS 2 0.0008
510 HYPOPHOSPHATAEMIA 6 0.0008
511 RETROPERITONEAL HAEMORRHAGE 2 0.0008
512 INTRAVENTRICULAR HAEMORRHAGE 2 0.0008
513 URINE OUTPUT DECREASED 7 0.0008
514 DERMATITIS EXFOLIATIVE 4 0.0008
515 CHRONIC SINUSITIS 3 0.0008
516 MYOCARDIAL ISCHAEMIA 9 0.0008
517 DRUG ERUPTION 14 0.0008
518 TOXIC ENCEPHALOPATHY 4 0.0008
519 AMMONIA INCREASED 4 0.0008
520 ENTERITIS 5 0.0008
521 HAEMOGLOBIN ABNORMAL 5 0.0008
522 SINUS TACHYCARDIA 11 0.0008
523 MELAENA 17 0.0008
524 LUNG INFECTION 12 0.0008
525 HAEMORRHAGIC STROKE 6 0.0008
526 RENAL FAILURE 102 0.0008
527 LUNG OPACITY 2 0.0008
528 SERUM FERRITIN INCREASED 4 0.0008
529 RENAL CYST 6 0.0008
530 CEREBRAL ATROPHY 3 0.0008
531 ANAL FISTULA 4 0.0007
532 ANION GAP INCREASED 1 0.0007
533 SHOCK 17 0.0007
534 RECURRENT CANCER 3 0.0007
535 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 7 0.0007
536 GINGIVAL BLEEDING 10 0.0007
537 ACUTE HEPATIC FAILURE 10 0.0007
538 CARDIOMEGALY 9 0.0007
539 GALLBLADDER DISORDER 13 0.0007
540 HYPOMAGNESAEMIA 10 0.0007
541 PULSELESS ELECTRICAL ACTIVITY 3 0.0007
542 PROCTITIS 2 0.0007
543 INTESTINAL STENOSIS 3 0.0007
544 RENAL TUBULAR DISORDER 2 0.0007
545 HYPOTENSION 142 0.0007
546 GASTROINTESTINAL HAEMORRHAGE 59 0.0007
547 RESPIRATORY SYMPTOM 2 0.0007
548 HEPATIC PAIN 3 0.0007
549 DUODENAL ULCER HAEMORRHAGE 2 0.0007
550 BLOOD POTASSIUM DECREASED 21 0.0007
551 INFECTION 101 0.0007
552 EPISTAXIS 52 0.0007
553 RALES 4 0.0007
554 CYTOMEGALOVIRUS INFECTION REACTIVATION 3 0.0007
555 BLOOD CREATINE INCREASED 3 0.0007
556 CHOLESTASIS 13 0.0007
557 PLEURISY 4 0.0007
558 HISTIOCYTOSIS HAEMATOPHAGIC 2 0.0007
559 CREPITATIONS 2 0.0007
560 GASTROINTESTINAL INFECTION 6 0.0007
561 JAUNDICE 18 0.0007
562 ATYPICAL PNEUMONIA 2 0.0007
563 RESPIRATORY DISORDER 20 0.0007
564 ANAEMIA 127 0.0007
565 HEPATITIS CHOLESTATIC 4 0.0007
566 LEUKOCYTOSIS 12 0.0007
567 PNEUMONITIS 18 0.0007
568 HIDRADENITIS 6 0.0007
569 LIPASE INCREASED 5 0.0007
570 CANDIDA INFECTION 11 0.0007
571 PORTAL HYPERTENSION 2 0.0006
572 OESOPHAGITIS 7 0.0006
573 CHOLELITHIASIS 21 0.0006
574 EPSTEIN-BARR VIRUS INFECTION 4 0.0006
575 BLOOD CREATININE DECREASED 2 0.0006
576 TORSADE DE POINTES 5 0.0006
577 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
578 NON-CARDIAC CHEST PAIN 2 0.0006
579 VENTRICULAR FIBRILLATION 7 0.0006
580 BLADDER PAIN 2 0.0006
581 MALNUTRITION 7 0.0006
582 TACHYCARDIA 55 0.0006
583 MITRAL VALVE INCOMPETENCE 7 0.0006
584 HYPOVENTILATION 2 0.0006
585 HICCUPS 5 0.0006
586 PNEUMONIA 197 0.0006
587 INFUSION SITE HAEMORRHAGE 2 0.0006
588 EMBOLISM 5 0.0006
589 PNEUMOCYSTIS JIROVECII PNEUMONIA 6 0.0006
590 CEREBRAL HAEMATOMA 2 0.0006
591 PERICARDITIS 10 0.0006
592 HYPOTHERMIA 6 0.0006
593 SUPRAVENTRICULAR EXTRASYSTOLES 2 0.0006
594 BLOOD SODIUM DECREASED 11 0.0006
595 CACHEXIA 3 0.0006
596 ACUTE SINUSITIS 1 0.0006
597 VIITH NERVE PARALYSIS 2 0.0006
598 PARTIAL SEIZURES 3 0.0006
599 EMBOLIC STROKE 2 0.0006
600 IMMUNOSUPPRESSION 5 0.0006
601 LYMPHOCYTE COUNT DECREASED 10 0.0006
602 HAEMORRHAGE SUBCUTANEOUS 2 0.0006
603 METABOLIC ACIDOSIS 18 0.0006
604 ANAL ABSCESS 3 0.0006
605 CELLULITIS 28 0.0006
606 CARDIO-RESPIRATORY ARREST 23 0.0005
607 CARDIAC FAILURE 44 0.0005
608 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0005
609 HEPATIC ENCEPHALOPATHY 5 0.0005
610 FLANK PAIN 5 0.0005
611 RENAL IMPAIRMENT 44 0.0005
612 MYOCARDITIS 6 0.0005
613 HERPES VIRUS INFECTION 3 0.0005
614 MALIGNANT NEOPLASM PROGRESSION 53 0.0005
615 INTERSTITIAL LUNG DISEASE 25 0.0005
616 STOMATITIS 31 0.0005
617 VENOUS THROMBOSIS 2 0.0005
618 FURUNCLE 4 0.0005
619 TRICUSPID VALVE INCOMPETENCE 4 0.0005
620 AZOTAEMIA 2 0.0005
621 WEIGHT INCREASED 112 0.0005
622 LEUKOPENIA 25 0.0005
623 PLATELET COUNT ABNORMAL 3 0.0005
624 ORGAN FAILURE 2 0.0005
625 EMPHYSEMA 5 0.0005
626 FOETAL GROWTH RESTRICTION 3 0.0005
627 BRADYCARDIA 26 0.0005
628 LUNG DISORDER 24 0.0005
629 THERAPY NON-RESPONDER 22 0.0005
630 ENCEPHALOPATHY 12 0.0005
631 LARYNGEAL OEDEMA 3 0.0005
632 ANAL PRURITUS 1 0.0005
633 CYTOMEGALOVIRUS INFECTION 8 0.0005
634 CONGESTIVE CARDIOMYOPATHY 2 0.0005
635 UPPER GASTROINTESTINAL HAEMORRHAGE 8 0.0005
636 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
637 UTERINE HAEMORRHAGE 2 0.0005
638 LIVER FUNCTION TEST INCREASED 10 0.0005
639 UNRESPONSIVE TO STIMULI 12 0.0005
640 HAEMATOMA 12 0.0005
641 ASPIRATION 5 0.0005
642 PANCREATITIS 24 0.0005
643 CYTOMEGALOVIRUS VIRAEMIA 2 0.0004
644 HAEMOLYTIC ANAEMIA 4 0.0004
645 OXYGEN SATURATION DECREASED 25 0.0004
646 COLITIS ISCHAEMIC 3 0.0004
647 MYELOSUPPRESSION 16 0.0004
648 WHITE BLOOD CELL COUNT INCREASED 17 0.0004
649 STATUS EPILEPTICUS 5 0.0004
650 VASCULAR DEVICE INFECTION 2 0.0004
651 DRUG TOXICITY 6 0.0004
652 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
653 IMMUNE THROMBOCYTOPENIA 2 0.0004
654 PNEUMONIA BACTERIAL 4 0.0004
655 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
656 CARDIOVASCULAR DISORDER 11 0.0004
657 LARGE INTESTINE PERFORATION 3 0.0004
658 HYPERTRANSAMINASAEMIA 3 0.0004
659 BLOOD POTASSIUM INCREASED 7 0.0004
660 HAEMORRHAGE 45 0.0004
661 AGRANULOCYTOSIS 8 0.0004
662 ELECTROLYTE IMBALANCE 5 0.0004
663 HAEMOPTYSIS 12 0.0004
664 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 1 0.0004
665 POST PROCEDURAL HAEMORRHAGE 5 0.0004
666 DIARRHOEA HAEMORRHAGIC 4 0.0004
667 VENTRICULAR TACHYCARDIA 7 0.0004
668 COVID-19 PNEUMONIA 5 0.0004
669 HYPOCALCAEMIA 8 0.0004
670 HAEMATOTOXICITY 4 0.0004
671 INTERNATIONAL NORMALISED RATIO INCREASED 12 0.0004
672 PULSE ABSENT 2 0.0004
673 CARDIOGENIC SHOCK 6 0.0004
674 HEPARIN-INDUCED THROMBOCYTOPENIA 2 0.0004
675 DEPRESSED LEVEL OF CONSCIOUSNESS 16 0.0004
676 INFLAMMATORY MARKER INCREASED 2 0.0004
677 SMALL FOR DATES BABY 2 0.0004
678 INTENTIONAL PRODUCT USE ISSUE 35 0.0004
679 TOXIC SKIN ERUPTION 4 0.0004
680 ABDOMINAL DISTENSION 41 0.0004
681 HEPATIC CYTOLYSIS 5 0.0004
682 ABDOMINAL INFECTION 1 0.0004
683 PROCEDURAL COMPLICATION 3 0.0004
684 HEPATITIS 10 0.0004
685 AORTIC ARTERIOSCLEROSIS 1 0.0004
686 TRISMUS 2 0.0004
687 OEDEMA 21 0.0004
688 ACTINIC KERATOSIS 1 0.0004
689 FAILURE TO THRIVE 2 0.0004
690 TONSILLITIS 2 0.0004
691 ATRIAL FLUTTER 3 0.0004
692 HEPATIC STEATOSIS 7 0.0004
693 GENERAL PHYSICAL HEALTH DETERIORATION 43 0.0004
694 GINGIVITIS 2 0.0004
695 CHEILITIS 2 0.0004
696 ABDOMINAL RIGIDITY 1 0.0004
697 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
698 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 3 0.0004
699 CARDIAC ARREST 30 0.0004
700 DRUG LEVEL BELOW THERAPEUTIC 2 0.0004
701 ELECTROCARDIOGRAM QT PROLONGED 13 0.0004
702 NECROSIS 2 0.0004
703 ORAL HERPES 7 0.0004
704 DISEASE RECURRENCE 17 0.0004
705 SKIN INFECTION 4 0.0004
706 HEMIPARESIS 6 0.0004
707 ACUTE LYMPHOCYTIC LEUKAEMIA 1 0.0004
708 PERONEAL NERVE PALSY 2 0.0004
709 GRANULOCYTOPENIA 2 0.0004
710 ANURIA 3 0.0003
711 ADENOVIRUS INFECTION 1 0.0003
712 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
713 METABOLIC DISORDER 2 0.0003
714 STRESS CARDIOMYOPATHY 2 0.0003
715 CAESAREAN SECTION 4 0.0003
716 ACUTE KIDNEY INJURY 52 0.0003
717 PULMONARY HYPERTENSION 7 0.0003
718 PATHOGEN RESISTANCE 3 0.0003
719 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
720 NO THERAPEUTIC RESPONSE 4 0.0003
721 DIVERTICULITIS 9 0.0003
722 ALTERED STATE OF CONSCIOUSNESS 7 0.0003
723 CHOLANGITIS 2 0.0003
724 PHARYNGITIS 4 0.0003
725 PNEUMOTHORAX 5 0.0003
726 WHITE BLOOD CELL COUNT ABNORMAL 2 0.0003
727 POST PROCEDURAL COMPLICATION 6 0.0003
728 SINUS BRADYCARDIA 3 0.0003
729 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
730 RENAL TUBULAR NECROSIS 3 0.0003
731 PRODUCT PREPARATION ISSUE 2 0.0003
732 ORAL CANDIDIASIS 4 0.0003
733 RECTAL HAEMORRHAGE 13 0.0003
734 HYPERGLYCAEMIA 11 0.0003
735 CYTOKINE RELEASE SYNDROME 6 0.0003
736 CROHN'S DISEASE 2 0.0003
737 ECCHYMOSIS 2 0.0003
738 PERITONITIS 6 0.0003
739 TENDERNESS 3 0.0003
740 ATRIAL FIBRILLATION 28 0.0003
741 ORTHOSTATIC HYPOTENSION 5 0.0003
742 CARDIAC FAILURE CONGESTIVE 23 0.0003
743 FOLLICULITIS 3 0.0003
744 HYPERKALAEMIA 10 0.0003
745 BLOOD TEST ABNORMAL 4 0.0003
746 PULMONARY TOXICITY 2 0.0003
747 HEPATOCELLULAR INJURY 4 0.0003
748 DIVERTICULUM 2 0.0003
749 AMYLASE INCREASED 1 0.0003
750 CEREBRAL DISORDER 2 0.0003
751 CONDITION AGGRAVATED 82 0.0003
752 HYPERTENSIVE CRISIS 3 0.0003
753 NEPHROPATHY TOXIC 3 0.0003
754 RHABDOMYOLYSIS 11 0.0003
755 TROPONIN INCREASED 2 0.0003
756 DEEP VEIN THROMBOSIS 17 0.0003
757 MATERNAL DRUGS AFFECTING FOETUS 2 0.0003
758 VASCULITIS 3 0.0003
759 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
760 DRUG-INDUCED LIVER INJURY 8 0.0003
761 MYOCLONUS 3 0.0003
762 ABSCESS 4 0.0003
763 BLOOD DISORDER 2 0.0002
764 HYPONATRAEMIA 14 0.0002
765 LACTIC ACIDOSIS 8 0.0002
766 HEMIPLEGIA 2 0.0002
767 ACCIDENTAL EXPOSURE 1 0.0002
768 FLUID RETENTION 12 0.0002
769 AORTIC VALVE INCOMPETENCE 1 0.0002
770 ABSCESS LIMB 1 0.0002
771 ABDOMINAL PAIN 54 0.0002
772 HIATUS HERNIA 3 0.0002
773 SKIN SWELLING 2 0.0002
774 CONFUSIONAL STATE 37 0.0002
775 NEUROTOXICITY 4 0.0002
776 HYPERTENSION 48 0.0002
777 EYE HAEMORRHAGE 3 0.0002
778 ANAL INCONTINENCE 2 0.0002
779 PALLOR 6 0.0002
780 HEPATIC ENZYME INCREASED 15 0.0002
781 LOWER RESPIRATORY TRACT INFECTION 10 0.0002
782 CYSTITIS 7 0.0002
783 NERVE COMPRESSION 2 0.0002
784 GRAND MAL CONVULSION 2 0.0002
785 ERYTHEMA MULTIFORME 2 0.0002
786 COMA 10 0.0002
787 HERPES ZOSTER 12 0.0002
788 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
789 VAGINAL HAEMORRHAGE 9 0.0002
790 DIZZINESS POSTURAL 2 0.0002
791 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 11 0.0002
792 OFF LABEL USE 174 0.0002
793 FULL BLOOD COUNT DECREASED 4 0.0002
794 ABDOMINAL PAIN LOWER 5 0.0002
795 EYELID PTOSIS 2 0.0002
796 MOTOR DYSFUNCTION 2 0.0002
797 VOMITING 92 0.0002
798 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
799 ANAPHYLACTIC SHOCK 5 0.0002
800 VENTRICULAR EXTRASYSTOLES 2 0.0002
801 NERVOUS SYSTEM DISORDER 6 0.0002
802 TRANSFUSION 2 0.0002
803 ARRHYTHMIA 9 0.0002
804 PREMATURE DELIVERY 3 0.0002
805 WHEEZING 11 0.0002
806 HEART RATE INCREASED 18 0.0002
807 ANAPHYLACTIC REACTION 10 0.0002
808 BLOOD PRESSURE DECREASED 12 0.0002
809 DEHYDRATION 24 0.0002
810 INTESTINAL PERFORATION 2 0.0002
811 GASTRIC HAEMORRHAGE 2 0.0002
812 OEDEMA PERIPHERAL 21 0.0002
813 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
814 CARDIAC DISORDER 16 0.0002
815 SPINAL PAIN 2 0.0002
816 LYMPHADENOPATHY 6 0.0002
817 PULMONARY EMBOLISM 16 0.0002
818 ISCHAEMIC STROKE 3 0.0002
819 MUSCLE RIGIDITY 2 0.0002
820 LIVER INJURY 4 0.0002
821 SMALL INTESTINAL OBSTRUCTION 2 0.0002
822 HYPERCALCAEMIA 2 0.0002
823 CONJUNCTIVITIS 3 0.0002
824 GENERALISED OEDEMA 2 0.0002
825 DIARRHOEA 104 0.0002
826 INTESTINAL OBSTRUCTION 6 0.0002
827 MYALGIA 27 0.0002
828 RASH GENERALISED 4 0.0002
829 NODULE 2 0.0002
830 MENORRHAGIA 3 0.0002
831 PULMONARY CONGESTION 2 0.0002
832 SINUS DISORDER 3 0.0002
833 DEATH 130 0.0002
834 HYPERSENSITIVITY 28 0.0002
835 RENAL DISORDER 7 0.0002
836 DYSPNOEA 85 0.0002
837 URINARY RETENTION 5 0.0001
838 DELIRIUM 5 0.0001
839 FEELING COLD 4 0.0001
840 CARPAL TUNNEL SYNDROME 2 0.0001
841 LYMPHOPENIA 2 0.0001
842 EATING DISORDER 3 0.0001
843 NAUSEA 110 0.0001
844 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
845 FAECES DISCOLOURED 3 0.0001
846 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
847 PRODUCT PRESCRIBING ISSUE 3 0.0001
848 BONE PAIN 8 0.0001
849 AGITATION 10 0.0001
850 SKIN HAEMORRHAGE 2 0.0001
851 EYE SWELLING 5 0.0001
852 PULMONARY MASS 2 0.0001
853 IMMUNODEFICIENCY 2 0.0001
854 CHROMATURIA 3 0.0001
855 DYSPNOEA EXERTIONAL 5 0.0001
856 EPILEPSY 4 0.0001
857 MUSCULOSKELETAL CHEST PAIN 2 0.0001
858 RASH PRURITIC 7 0.0001
859 CYANOSIS 2 0.0001
860 DISORIENTATION 5 0.0001
861 RASH ERYTHEMATOUS 6 0.0001
862 SCIATICA 2 0.0001
863 CHEST PAIN 23 0.0001
864 DRUG INEFFECTIVE 163 0.0001
865 CEREBRAL INFARCTION 3 0.0001
866 CONVULSION 7 0.0001
867 ABNORMAL FAECES 1 0.0001
868 LETHARGY 7 0.0001
869 SEIZURE 14 0.0001
870 TREATMENT FAILURE 10 0.0001
871 MYOCARDIAL INFARCTION 21 0.0001
872 NEOPLASM MALIGNANT 8 0.0001
873 TOXICITY TO VARIOUS AGENTS 20 0.0001
874 CIRCULATORY COLLAPSE 2 0.0001
875 HYPOPHAGIA 3 0.0001
876 SEDATION 3 0.0001
877 LOSS OF CONSCIOUSNESS 14 0.0001
878 DYSURIA 4 0.0001
879 NECK PAIN 6 0.0001
880 SINUSITIS 11 0.0001
881 HEPATIC CIRRHOSIS 2 0.0001
882 PHOTOPHOBIA 2 0.0001
883 SLEEP APNOEA SYNDROME 2 0.0001
884 ANGINA PECTORIS 3 0.0001
885 HYPOGLYCAEMIA 5 0.0001
886 TREMOR 17 0.0001
887 ABDOMINAL PAIN UPPER 21 0.0001
888 ACUTE MYOCARDIAL INFARCTION 3 0.0001
889 SYNCOPE 10 0.0001
890 THROMBOSIS 8 0.0001
891 EMOTIONAL DISTRESS 12 0.0001
892 PRODUCT USE IN UNAPPROVED INDICATION 24 0.0001
893 PRODUCT USE ISSUE 18 0.0001
894 HEAD INJURY 3 0.0001
895 SOMNOLENCE 19 0.0001
896 RETCHING 2 0.0001
897 RASH 40 0.0001
898 HAEMATOCHEZIA 5 0.0001
899 PANCREATITIS ACUTE 2 0.0001
900 MALAISE 38 0.0001
901 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
902 MENTAL IMPAIRMENT 2 0.0001
903 PRESYNCOPE 2 0.0001
904 RESTLESSNESS 3 0.0001
905 ABASIA 2 0.0001
906 BLOOD PRESSURE INCREASED 12 0.0001
907 COUGH 22 0.0001
908 HYPERHIDROSIS 10 0.0001
909 BACK PAIN 18 0.0001
910 DIPLOPIA 2 0.0001
911 ABNORMAL BEHAVIOUR 3 0.0001
912 FALL 25 0.0001
913 RESPIRATORY ARREST 2 0.0001
914 PAIN 43 0.0001
915 CONSTIPATION 15 0.0001
916 DYSSTASIA 2 0.0001
917 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
918 URINARY INCONTINENCE 2 0.0001
919 PREMATURE BABY 2 0.0001
920 UNEVALUABLE EVENT 5 0.0001
921 THERAPEUTIC RESPONSE DECREASED 4 0.0001
922 SKIN DISCOLOURATION 3 0.0001
923 COGNITIVE DISORDER 3 0.0001
924 ASTHENIA 24 0.0001
925 DRUG INTERACTION 10 0.0001
926 FATIGUE 49 0.0001
927 COVID-19 11 0.0001
928 EYE DISORDER 2 0.0001
929 DECREASED APPETITE 14 0.0001
930 VISUAL ACUITY REDUCED 2 0.0001
931 VIRAL INFECTION 2 0.0001
932 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
933 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
934 RASH MACULAR 2 0.0001
935 HEART RATE DECREASED 2 0.0001
936 OROPHARYNGEAL PAIN 5 0.0001
937 ERYTHEMA 11 0.0001
938 DYSARTHRIA 2 0.0001
939 FLATULENCE 3 0.0001
940 DYSPEPSIA 5 0.0001
941 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
942 IRRITABILITY 3 0.0000
943 BLINDNESS 2 0.0000
944 BLOOD GLUCOSE INCREASED 9 0.0000
945 HEADACHE 29 0.0000
946 PRURITUS 17 0.0000
947 NEPHROLITHIASIS 2 0.0000
948 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
949 SWELLING 4 0.0000
950 DYSPHAGIA 4 0.0000
951 NEUROPATHY PERIPHERAL 4 0.0000
952 PRODUCTIVE COUGH 2 0.0000
953 BLOOD GLUCOSE DECREASED 2 0.0000
954 CEREBROVASCULAR ACCIDENT 7 0.0000
955 BRONCHITIS 3 0.0000
956 DYSGEUSIA 3 0.0000
957 AGEUSIA 1 0.0000
958 DRY EYE 2 0.0000
959 HALLUCINATION 3 0.0000
960 INFLAMMATION 2 0.0000
961 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
962 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
963 MEDICATION ERROR 2 0.0000
964 INFLUENZA 4 0.0000
965 WEIGHT DECREASED 10 0.0000
966 MUSCULAR WEAKNESS 4 0.0000
967 BALANCE DISORDER 3 0.0000
968 INSOMNIA 9 0.0000
969 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
970 GASTROINTESTINAL DISORDER 3 0.0000
971 ADVERSE DRUG REACTION 3 0.0000
972 RHINORRHOEA 2 0.0000
973 PAIN IN EXTREMITY 9 0.0000
974 URINARY TRACT INFECTION 5 0.0000
975 CHEST DISCOMFORT 3 0.0000
976 INJECTION SITE REACTION 2 0.0000
977 ARTHRALGIA 12 0.0000
978 DIZZINESS 14 0.0000
979 ACCIDENTAL OVERDOSE 1 0.0000
980 DEPRESSION 6 0.0000
981 DRY MOUTH 2 0.0000
982 VISUAL IMPAIRMENT 3 0.0000
983 MUSCLE SPASMS 4 0.0000
984 GAIT DISTURBANCE 4 0.0000
985 FEELING ABNORMAL 5 0.0000
986 CONTUSION 2 0.0000
987 FLUSHING 2 0.0000
988 URTICARIA 3 0.0000
989 AMNESIA 1 0.0000
990 MEMORY IMPAIRMENT 2 0.0000
991 ANXIETY 4 0.0000
992 HYPOAESTHESIA 2 0.0000
993 PARAESTHESIA 2 0.0000
994 ABDOMINAL DISCOMFORT 2 0.0000
995 INCORRECT DOSE ADMINISTERED 2 0.0000
996 ALOPECIA 1 0.0000